• 作者：J.M. Carrascosa^a ; ^{jmcarrascosac@hotmail.com} ; J.L. Ló ; pez-Estebaranz^b ; G. Carretero^c ; E. Daudé ; n^d ; C. Ferrá ; ndiz^a ; D. Vidal^e ; I. Belinchó ; n^f ; M. Sá ; nchez-Regañ ; a^g ; L. Puig^h ; Grupo Españ ; ol de Psoriasis de la Academia Españ ; ola de Dermatologí ; a y Venereologí ; a
• 关键词：Fototerapia ; HUBE ; Psoriasis ; Terapia fotodiná ; mica ; Excí ; mero
• 刊名：Actas Dermo-Sifiliogr谩ficas
• 出版年：2011
• 期刊代码：pca35_00017310
• 类别：med
• 出版时间：April 2011
• 卷：102
• 期：3
• 页码：175-186
• 文件大小：272 K

Novel treatment strategies and new information concerning the management of moderate to severe psoriasis justify a reassessment of the role of the classic therapies in this setting. This consensus statement evaluates narrowband UV-B therapy, which is currently considered the phototherapy option of choice in psoriasis because of its risk-to-benefit ratio. The role of excimer laser and photodynamic therapies are also discussed. These targeted therapies are still only available in a small number of centers in Spain and are used principally in the treatment of localized and recalcitrant forms of psoriasis. We discuss the efficacy and safety of phototherapy as well as treatment regimens, combination therapy, and clinical considerations relating to the characteristics of the patient or the disease.